Chemokine receptor 9 (CCR9) is required for the homeostatic recruitment of T cells to the mucosa of the small intestine. Accordingly, CCR9 has been suggested as a potential target to inhibit the recruitment of proinflammatory effector T cells (Teff) in inflammatory bowel disease (IBD). Since the contribution of CCR9 to the recruitment of Teff in inflammation is not entirely clear, we aimed to address this question using IFABPtOva mice. These mice express Ovalbumin (Ova) specifically in small intestinal epithelial cells, which allows triggering of acute inflammation following transfer of Ova-specific CD8+ T cells (OT-I cells) and adjuvant treatment. Strikingly, intestinal inflammation in IFABP-tOva mice could also be triggered following transfer of CCR9-deficient OT-I cells, demonstrating that CCR9 is not required for homing of Teff cells. Interestingly, OTI cells transferred to IFABP-tOva mice did not only differentiate into Teff, but also into FoxP3+ CD8+ Tregs, which in contrast to Teff cells expressed high levels of CCR9. Indeed, recruitment and expansion of this regulatory subset in the small intestine was strongly dependent on CCR9. Hence, our data show that Teff and regulatory T cell subsets use distinct mechanisms for migration to the small intestine and suggest that inhibition of CCR9 in IBD could be more harmful than useful.
|Number of pages||1|
|Publication status||Published - 2015|
|Event||17th International Congress of Mucosal Immunology - Maritim Hotel, Berlin, Germany|
Duration: 14 Jul 2015 → 18 Jul 2015
|Conference||17th International Congress of Mucosal Immunology|
|Period||14/07/2015 → 18/07/2015|